Alibaba is finding buying support above the recent $205 low. We expect the earnings picture to improve over the next 12 months as a result of the regulatory impacts subsiding.
CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.
ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.
PDD:NAS is now under Algo Engine buy conditions. The company is China’s largest agriculture and interactive commerce platform.
Pinduoduo has surpassed Alibaba as China’s largest e-commerce company with 788 million active users according to its latest quarterly earnings report.
We expect buying interest to build above the $125 support level.
Q121 earnings showed continued growth with revenue increasing 239% to 22.2 billion yuan ($3.4 billion) in the three months ended March, beating consensus analyst estimates.
The number of annual active buyers for the 12 months ended March increased to 823.8 million, making Pinduoduo the most widely used e-commerce platform in China.
Incitec Pivot is now under Algo Engine buy conditions.
The company reported 1H21 Sales of $1.72m with underlying EBITDA of $286m. The EBIT miss was primarily driven by Fertilizers and Dyno Americas, with Dyno APAC largely in-line.
Our Option Lab AI technology suggests looking at the following call.
Send our ASX Research to your Inbox
Or start a free thirty day trial for our full service, which includes our ASX Research.